(Eli Lilly and Company) – Jackie has worked tirelessly to ensure the right voices are heard and the right information is seen by Indiana lawmakers and has encouraged the right level of access for patients and protections that ensure a successful environment for medical innovators in the state, while also finding data that proves how
Marci has raised awareness of women’s health needs and research efforts at Astellas to treat them. She has discussed the stigma around talking about menopause and other aspects of women’s health. At the same time, Marci joined researchers from companies around the country to meet with members of Congress and their staff to discuss their
(Bayer) – Dr. Zampaglione is passionate about ensuring all women have access to the information and support they need to take control of their health. He is a champion of Bayer’s support of patient education on family planning through advocacy partnerships.
(Boehringer Ingelheim) – Dr. Palmisano is a leading advocate for Boehringer Ingelheim who regularly engages with external stakeholders to support the industry and demonstrate its value to patients and policymakers. Her passion for pediatric therapies has also led her to participate in FDA dialogues on sound policies for pediatric drug development.
(GlaxoSmithKline) Dr. Schnackenberg chairs GSK’s Science in the Schools group in Upper Merion, PA. This volunteer group works to provide opportunities for GSK employees to share science in their local communities and inspire future generations of scientists.
Outside of Kristie’s role at Bristol-Myers Squibb (BMS), she is a Helping Hands Volunteer Program Administrator, coordinating employee engagement for service hours to charities. In 2017, more than 1,400 volunteers gave over 6,200 volunteer hours and participated in 65 events. Kristie also leads employee community outreach with the Salvation Army Backpack Drive, Bentley Community Services,
As Lilly develops facilities plans across the country and worldwide, D.R. includes the Government Affairs team in the planning process to help understand assets on the ground in high-impact locations and how a policy shift might change the economic metrics of a decision. He has a deep knowledge of the industry, and when Lilly engages
Marilyn Foote-Hudson has served as the executive director of the North Carolina GlaxoSmithKline Foundation for over a decade, exhibiting leadership and dedication to the countless number of lives she has touched in the state. Marilyn supports and delivers science and health education programs across the state to those in kindergarten through high school. In addition,
Danielle started as an intern at Boehringer Ingelheim (BI) and worked her way up to a lab manager, where she now trains the next generation of scientists. Over the past two years, Danielle has helped spearhead R&D support for facility tours at the U.S. headquarters, showing federal and state policymakers first-hand the important work that
Dr. Fradette has taken time outside of work to enlighten policymakers about industry risks, science and challenges. She showcases her relentless commitment for patients by amplifying their voices to members of Congress, the FDA and at medical conferences across the world.